Financials

  • Market Capitalization 5.28 B
  • Employee 497
  • Founded 2011
  • CEO N/A
  • Website www.travere.com
  • Headquarter California, United States
  • FIGI BBG000P9D6W9
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-131.76
ratio cours/chiffre d'affaires
6.95

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1239
BLTE
Belite Bio Inc - American Depositary Shares
149.47 USD+1.90%-1.81%+9.78%+140.31%5.88 B USD
1285
DNTH
Dianthus Therapeutics, Inc. - Common Stock
99.91 USD-1.35%+1.14%+26.48%+404.09%5.46 B USD
1351
DFTX
Definium Therapeutics, Inc. - Common Shares
45.66 USD-0.70%+0.93%+89.15%+202.18%4.98 B USD
1356
CRSP
CRISPR Therapeutics AG - Common Shares
51.37 USD+1.80%-13.28%-2.80%-8.02%4.95 B USD

Nouvelles